The News Feed


DME Patients Face Delay in Anti-VEGF Therapy

These extended intervals could explain the suboptimal therapy outcomes, researchers suggest.
August 4, 2021

Nonadherent DME Patients Pay a Small Price After Stopping Anti-VEGF

However, study shows VA improved after restarting therapy to the level seen prior to the treatment break.
July 27, 2021

Same DME Biomarker, Different Angle

Keeping tabs on central subfield thickness fluctuations over time, rather than on single measurements, may help clinicians better predict visual acuity outcomes, study suggests.
July 26, 2021

The Future is Here: “Telephotocoagulation” for Diabetic Retinopathy Debuts

All patients had smooth, successful treatments—performed remotely—in this small study.
July 14, 2021

Anti-VEGF Surpasses PRP for PDR Treatment

Intravitreal injection with bevacizumab was the most common, study finds.
July 8, 2021

Telemed Screenings for Diabetic Eye Disease Sufficient, But Not Error-Free

PCP-led remote exams were considered worthwhile 84% of the time in a recent study.
June 28, 2021

DR Severity Associated with Corneal Endothelial Changes

Study also highlights impact of diabetes duration and age.
June 17, 2021

UWF Imaging Earns Good Marks in Detecting Early DR

Still, this technique was less sensitive than standard techniques in finding intraretinal microvascular abnormalities, researchers report.
June 8, 2021

NPDR Follow-up Affected by Insurance, Appointment Intervals

Considering the overall adherence rate was 53%, researchers say extra effort is needed to ensure diabetic patients return to the clinic for continual care.
June 7, 2021

Minority Youth Less Likely to Undergo Diabetic Eye Exams

These individuals were also five times more likely to have DR than their white counterparts, study finds.
June 7, 2021